BR0215044A - Matriz de comprimidos revestidos com pelìcula com liberação controlada de misturas naturais de estrogênios conjugados - Google Patents

Matriz de comprimidos revestidos com pelìcula com liberação controlada de misturas naturais de estrogênios conjugados

Info

Publication number
BR0215044A
BR0215044A BR0215044-1A BR0215044A BR0215044A BR 0215044 A BR0215044 A BR 0215044A BR 0215044 A BR0215044 A BR 0215044A BR 0215044 A BR0215044 A BR 0215044A
Authority
BR
Brazil
Prior art keywords
controlled release
release film
coated tablet
conjugated estrogen
tablet matrix
Prior art date
Application number
BR0215044-1A
Other languages
English (en)
Inventor
Bernd Thumbeck
Klaus Budde
Gerhard Kristen
Margit Wiards
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BR0215044A publication Critical patent/BR0215044A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

"MATRIZ DE COMPRIMIDOS REVESTIDOS COM PELìCULA COM LIBERAçãO CONTROLADA DE MISTURAS NATURAIS DE ESTROGêNIOS CONJUGADOS". A presente invenção refere-se a uma matriz farmacêutica de comprimidos revestidos com película com liberação controlada de misturas naturais de estrogênios conjugados, que foram obtidos a partir de urina de éguas prenhas.
BR0215044-1A 2001-12-14 2002-12-12 Matriz de comprimidos revestidos com pelìcula com liberação controlada de misturas naturais de estrogênios conjugados BR0215044A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01129830 2001-12-14
PCT/EP2002/014103 WO2003051336A1 (de) 2001-12-14 2002-12-12 Matrix-filmtablette mit kontrollierter freisetzung von natürlichen gemischen konjugierter oestrogene

Publications (1)

Publication Number Publication Date
BR0215044A true BR0215044A (pt) 2004-11-03

Family

ID=8179548

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215044-1A BR0215044A (pt) 2001-12-14 2002-12-12 Matriz de comprimidos revestidos com pelìcula com liberação controlada de misturas naturais de estrogênios conjugados

Country Status (19)

Country Link
US (1) US8268351B2 (pt)
EP (1) EP1465602B1 (pt)
JP (1) JP4695837B2 (pt)
CN (1) CN100542538C (pt)
AR (1) AR037760A1 (pt)
AT (1) ATE438384T1 (pt)
AU (1) AU2002361396B2 (pt)
BR (1) BR0215044A (pt)
CA (1) CA2470207C (pt)
DE (1) DE50213751D1 (pt)
DK (1) DK1465602T3 (pt)
ES (1) ES2328910T3 (pt)
HK (1) HK1075005A1 (pt)
MX (1) MXPA04005769A (pt)
PL (1) PL205739B1 (pt)
PT (1) PT1465602E (pt)
SI (1) SI1465602T1 (pt)
TW (1) TWI252111B (pt)
WO (1) WO2003051336A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
MXPA04008100A (es) * 2002-02-21 2005-06-17 Biovail Lab Int Srl Formulaciones de liberacion modificada de al menos una forma de tramadol.
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
GB0329498D0 (en) * 2003-12-19 2004-01-28 Novartis Ag Organic compounds
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
EP1679065A1 (en) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
JP4864024B2 (ja) * 2008-02-15 2012-01-25 エスエス製薬株式会社 時限放出製剤
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753767A (en) * 1971-08-02 1973-08-21 Colgate Palmolive Co Method of sugar-coating tablets
DE3535536A1 (de) * 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
HU9500322D0 (en) * 1994-02-08 1995-03-28 Solvay Deutschland Process for separating estrogenes from the urine of mares with foal
US5458887A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
DE4447714C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
CN1101682C (zh) * 1996-08-30 2003-02-19 索尔瓦药物有限公司 由牝马尿液获取雌激素的方法
CN1101683C (zh) * 1996-08-30 2003-02-19 索尔瓦药物有限公司 由牝马尿获取雌激素的方法
ES2219697T3 (es) 1996-08-30 2004-12-01 Solvay Pharmaceuticals Gmbh Proceso para la obtencion de estrogenos a partir de la orina de yeguas.
CA2263757C (en) * 1996-08-30 2007-10-23 Solvay Deutschland Gmbh Method to obtain oestrogens from mare's urine
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
ATE433318T1 (de) * 1999-02-10 2009-06-15 Pfizer Prod Inc Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
PT1183014E (pt) * 1999-06-14 2003-12-31 Cosmo Spa Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy

Also Published As

Publication number Publication date
MXPA04005769A (es) 2004-09-10
CN100542538C (zh) 2009-09-23
PT1465602E (pt) 2009-09-07
ATE438384T1 (de) 2009-08-15
PL369367A1 (en) 2005-04-18
EP1465602B1 (de) 2009-08-05
WO2003051336A1 (de) 2003-06-26
DK1465602T3 (da) 2009-09-28
AR037760A1 (es) 2004-12-01
US20050019408A1 (en) 2005-01-27
AU2002361396B2 (en) 2008-02-14
TWI252111B (en) 2006-04-01
TW200408414A (en) 2004-06-01
ES2328910T3 (es) 2009-11-19
JP2005513059A (ja) 2005-05-12
SI1465602T1 (sl) 2009-12-31
EP1465602A1 (de) 2004-10-13
JP4695837B2 (ja) 2011-06-08
CN1607943A (zh) 2005-04-20
AU2002361396A1 (en) 2003-06-30
PL205739B1 (pl) 2010-05-31
CA2470207A1 (en) 2003-06-26
CA2470207C (en) 2012-07-10
DE50213751D1 (de) 2009-09-17
US8268351B2 (en) 2012-09-18
HK1075005A1 (en) 2005-12-02

Similar Documents

Publication Publication Date Title
BR0215044A (pt) Matriz de comprimidos revestidos com pelìcula com liberação controlada de misturas naturais de estrogênios conjugados
BR0215193A (pt) Formulações de azitromicina diretamente compressìveis
BRPI0410645A (pt) derivados de aril-carbaldeìdo oxima e sua aplicação como agentes estrogênicos
KR880007084A (ko) 제약 조성물
BR0015188A (pt) Composições farmacêuticas
ES2178510A1 (es) Composiciones farmaceuticas de micofenolato revestidas entericamente.
NZ507271A (en) Fast disintegrating tablets
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
NO971206D0 (no) Forlenget-frigjöringsformulering
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
NZ514574A (en) Novel method of treatment
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
RU97104120A (ru) Фармацевтические композиции, содержащие производные эстра-1,3,5(10)-триена
HK1175846A1 (en) Cytotoxicity mediation of cells evidencing surface expression of cd44 cd44
PA8638201A1 (es) Forma cristalina alfa del ranelato de estroncio procedimiento para su preparacion y composiciones farmaceuticas que la contienen
BR0215801A (pt) Derivados de 3,6-dissubstituìdos azabiciclo [3.1.0] hexano úteis como antagonistas de receptores muscarìnicos
ATE515493T1 (de) Mercaptophenylnaphthylmethan-derivate und deren herstellung
BR0111868A (pt) Composições farmacêuticas
WO2003028631A3 (en) Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
BR0307320A (pt) Sistema de liberação osmótico
PE20031047A1 (es) Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA.INT.CI.A61K 9/16, A61K 9/28, A61K 9/20, A61P 15/00

Ipc: A61K 9/16 (2011.01), A61K 9/28 (2011.01), A61K 9/2

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: ABBOTT PRODUCTS GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE. PAGAR RESTAURACAO.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2259 DE 22/04/2014

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time